Discontinuation report PREGABALIN
| Report ID | 53360 |
| Drug Identification Number | 02403706 |
| Brand name | PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-06-29 |
| Remaining supply date | 2018-06-29 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | 500 count format no longer available for the time being |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-02-14 | French | Compare |
| v4 | 2022-02-14 | English | Compare |
| v3 | 2018-06-30 | English | Compare |
| v2 | 2018-06-29 | French | Compare |
| v1 | 2018-06-29 | English | Compare |
Showing 1 to 5 of 5